Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
patients with prostate cancer who have just undergone prostatectomy,
high risk of their cancer recurring (High risk is defined as at least a 50 percent chance the cancer will return within three years after surgery.)
You may not be if
Prior systemic treatment for prostate cancer with hormonal therapy, chemotherapy, or any other anticancer therapy.
Prior radiation therapy
Patients receiving any concurrent therapy for cancer. This includes alternative therapies
Patients requiring concurrent treatment with corticosteroids, with the exception of inhaled and topical corticosteroids.
History of a malignancy other than prostate cancer
Peripheral neuropathy \>/= Grade 2
Psychological, familial, sociological or geographical conditions which do not permit treatment and/or medical follow-up required to comply with the study protocol
Patients with a history of hypersensitivity reaction to products containing Polysorbate 80 (Tween 80).
Clareo Health | A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy
